ArticleBlood cancer journal2025

Venetoclax-based treatment combinations in relapsed/refractory multiple myeloma: practice patterns and impact of secondary cytogenetic abnormalities on outcomes.

Abiola Bolarinwa et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.